Eyebrow
Complementary solutions
Eyebrow
Complementary solutions
article list
Filspari® (sparsentan) – New indication <br>Qvar® (beclomethasone) – First-time generic<br>Farxiga® (dapagliflozin) – First-time generic<br>Incruse Ellipta® (umeclidinium) – First-time authorized brand alternative
Experience fast, simple, comprehensive image display and manipulation with a unified, cloud-native viewer.
Advance public health and safety with our trusted experts and data.
Drive results across the drug development lifecycle with real-world data, analytics and clinical expertise — helping you move from concept to impact faster.
Case study
Optum Life Sciences experts used real-world data to assist in the testing of an algorithm designed to assess for osteoporosis risk.